PPID horses may live as long, but with more medical events

PPID may not shorten a horse’s life, but it does appear to add medical complexity along the way. A new JAVMA study discussed in AVMA’s Veterinary Vertex podcast found that horses diagnosed with pituitary pars intermedia dysfunction, or PPID, had similar life expectancy to matched controls, even though they experienced more lifetime medical events. The study, led by Emma Stapley and colleagues at Purdue, compared 132 horses with PPID and 274 controls matched by age, breed type, and even pet parent, a design the authors said helped reduce referral and management bias. Across 2,914 recorded medical events, PPID horses were more likely to have hyperinsulinemia-associated laminitis, poor healing, NSAID use, and dental findings such as missing teeth or equine odontoclastic tooth resorption and hypercementosis. (pubmed.ncbi.nlm.nih.gov)

Why it matters: For equine veterinarians, the message is less about prognosis than management. The study suggests PPID isn’t automatically a shortened-life diagnosis, especially when horses are identified and treated, but it does come with a higher burden of monitoring and comorbidity. That has practical implications for how clinicians counsel pet parents: daily pergolide may be only one part of care, alongside laminitis surveillance, insulin testing, wound-healing vigilance, and more attention to oral health. The podcast authors also noted that frequent hands-on care may itself increase detection of subtle problems, which could partly explain the higher event count. (veterinaryvertex.buzzsprout.com)

What to watch: Expect follow-up work on how PPID intersects with aging, insulin dysregulation, and dental disease, as researchers try to sort true disease effects from increased monitoring in older horses. (veterinaryvertex.buzzsprout.com)